Heart attack clues: genetic test spots hidden cholesterol disorder
NCT ID NCT05218005
First seen May 06, 2026 · Last updated Jun 23, 2026 · Updated 8 times
Summary
This study tested whether offering genetic screening for Familial Hypercholesterolemia (FH) to patients under 60 hospitalized for a heart attack could increase diagnosis rates. Researchers enrolled 140 patients and performed a research-based genetic test for FH-causing gene variants. The goal was to see if this approach leads to more people being diagnosed and receiving intensified cholesterol-lowering treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
St.Pauls Hospital
Vancouver, British Columbia, V6Z 1Y6, Canada
-
Vancouver General Hospital
Vancouver, British Columbia, V5Z 1M9, Canada
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Research-based genetic test for Familial Hypercholesterolemia
What this could lead to
If successful, this approach could help identify more people with a genetic cause of high cholesterol after a heart attack, leading to better treatment and prevention of future events.
What could go wrong
This is a completed, relatively small study (140 participants) focused on diagnosis, not a treatment. The genetic test is research-based, not yet standard clinical practice, and results may not apply to all populations.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.